Article Details
Retrieved on: 2025-06-20 17:38:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
n Roche's Lunsumio and Polivy combination extends median progression-free survival to 11.5 months, three times longer than R-GemOx.
Article found on: www.gurufocus.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here